News from the FDA/CDC
News from the FDA/CDC
U.S. allows pharmacists to prescribe Paxlovid directly
“Since Paxlovid must be taken within 5 days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access...
News from the FDA/CDC
CDC recommends high-dose flu vaccines for seniors
These types of vaccines work by creating a larger immune response than a standard vaccine dose.
News from the FDA/CDC
FDA Class I recall: Batteries for CARESCAPE 2860 Ventilator
When using the backup power source, clinicians should make sure to have alternative routes for breathing support on hand.
News from the FDA/CDC
FDA Volara ventilator warning upgraded to full recall
News from the FDA/CDC
FDA orders Juul to stop selling E-cigarettes
The marketing denial order covers only the commercial distribution and retail sale of Juul’s products and doesn’t restrict consumer possession or...
News
FDA panel rejects pimavanserin for Alzheimer’s psychosis
The FDA will make its final decision by August 4.
News from the FDA/CDC
FDA approves risankizumab (Skyrizi) for Crohn’s disease
Risankizumab is already approved in the United States for the treatment of adults with active psoriatic arthritis and moderate to severe plaque...
News from the FDA/CDC
FDA warning released for Volara respiratory system
News from the FDA/CDC
FDA adds RA indication for Riabni rituximab biosimilar
Riabni is the second rituximab biosimilar to be approved for rheumatoid arthritis in the United States.
News
FDA denies petition to disqualify researchers over controversial ketamine studies
“The FDA denied our petition, and we think that sends the wrong signal to the research community.”
News
FDA approves first drug for eosinophilic esophagitis
Dupilumab (Dupixent) is approved to treat eosinophilic esophagitis in adults and children aged 12 years and older weighing at least 40 kg.